Collaborative Care Office-Based Opioid Treatment for Adolescents and Young Adults
Collaborative Care Office-Based Opioid Treatment for Adolescents and Young Adults
批准号:
10503568
负责人:
Scott Evan Hadland
金额:
$19.93万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-10-05 至 2023-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY:
Risk for opioid use disorder (OUD) often begins in adolescence and young adulthood. Engaging and retaining
adolescents and young adults (collectively, “youth”) in early, effective treatment to is critical in order to improve
the life course trajectory of addiction. For adults with OUD, office-based opioid treatment (OBOT) with a
collaborative care approach optimizes patient engagement and retention in care. This approach combines
physician visits, nurse care management, and behavioral therapy. Collaborative care OBOT is especially
promising for youth, who can receive treatment from a trusted primary care provider in the same familiar
setting they receive their usual medical care. To date, however, OBOT has not been formally adapted for
treating youth. The central objective of this project is to develop and pilot an OBOT model that is enhanced for
youth and that is developmentally appropriate and family-centered. The project includes: (1) an analysis of
Massachusetts Department of Public Health data to measure treatment patterns and outcomes among youth
with OUD, thus identifying periods of high risk for loss to follow-up and drug use relapse during treatment; (2)
qualitative interviews with youth, caretakers, and key informants (such as experienced OBOT providers and
primary care providers of youth in areas of high OUD prevalence) to determine necessary modifications to the
OBOT model for youth; and (3) a single-arm adaptive pilot study of OBOT enhanced for youth, using
implementation and improvement science techniques to optimize the intervention. The Principal Investigator,
Dr. Hadland, is an early career clinician-investigator with triple board certification in General Pediatrics,
Adolescent Medicine, and Addiction Medicine, and prior research experience in clinical epidemiology. With this
project, he seeks to enhance his skills in interventional research, focusing on developing analytic skills in
advanced survival analysis and use of correlated data, acquiring foundational knowledge in intervention
development, and using implementation and improvement science methodology to optimize an intervention
initially designed for adults for use among youth. Dr. Hadland will conduct this research at Boston Medical
Center and Boston University School of Medicine, national leaders in addiction medicine and research. The
project is supported by an interdisciplinary mentorship and advisory team with expertise in advanced
biostatistical analysis, qualitative research, intervention development, developmental psychology, and
implementation and improvement science.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Substance Use and Firearm Injuries among Medicaid-enrolled Youth
-
批准号:10811094
-
项目类别:
-
资助金额:$56.37万
-
财政年份:2023
-
负责人:Scott Evan Hadland
-
依托单位:
Identifying Disparities in the Cascade of Care for Medicaid-Enrolled Youth with Opioid Use Disorder
-
批准号:10584158
-
项目类别:
-
资助金额:$59.8万
-
财政年份:2022
-
负责人:Scott Evan Hadland
-
依托单位:
Identifying Disparities in the Cascade of Care for Medicaid-Enrolled Youth with Opioid Use Disorder
-
批准号:10701852
-
项目类别:
-
资助金额:$56.38万
-
财政年份:2022
-
负责人:Scott Evan Hadland
-
依托单位:
Collaborative Care Office-Based Opioid Treatment for Adolescents and Young Adults
-
批准号:10430164
-
项目类别:
-
资助金额:$19.91万
-
财政年份:2021
-
负责人:Scott Evan Hadland
-
依托单位:
Collaborative Care Office-Based Opioid Treatment for Adolescents and Young Adults
-
批准号:9979815
-
项目类别:
-
资助金额:$18.53万
-
财政年份:2018
-
负责人:Scott Evan Hadland
-
依托单位:
Collaborative Care Office-Based Opioid Treatment for Adolescents and Young Adults
-
批准号:10174899
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2018
-
负责人:Scott Evan Hadland
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于CARE解码框架的跨范式肌电无声语音识别新方法
-
批准号:2026JJ70025
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭欣
-
依托单位:
CarE06介导朱砂叶螨对甲氰菊酯对映体代谢抗性形成差异机制
-
批准号:CSTB2023NSCQ-MSX0916
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:张平
-
依托单位:
棉铃虫羧酸酯酶CarE001G在杀虫剂代谢和抗性中的作用及机制
-
批准号:U1903111
-
项目类别:联合基金项目
-
资助金额:57万元
-
批准年份:2019
-
负责人:李永强
-
依托单位:
棉铃虫羧酸酯酶CarE001C定向进化及突变酶的结构与功能研究
-
批准号:31201517
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:李永强
-
依托单位: